ZA200108263B - Novel recombinant and mutant herpesviruses. - Google Patents

Novel recombinant and mutant herpesviruses.

Info

Publication number
ZA200108263B
ZA200108263B ZA200108263A ZA200108263A ZA200108263B ZA 200108263 B ZA200108263 B ZA 200108263B ZA 200108263 A ZA200108263 A ZA 200108263A ZA 200108263 A ZA200108263 A ZA 200108263A ZA 200108263 B ZA200108263 B ZA 200108263B
Authority
ZA
South Africa
Prior art keywords
novel recombinant
herpesviruses
mutant
mutant herpesviruses
recombinant
Prior art date
Application number
ZA200108263A
Other languages
English (en)
Inventor
David E Junker
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of ZA200108263B publication Critical patent/ZA200108263B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200108263A 1999-04-09 2001-10-08 Novel recombinant and mutant herpesviruses. ZA200108263B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/289,254 US6299882B1 (en) 1999-04-09 1999-04-09 UL54.5 of Marek's disease virus (MDV)

Publications (1)

Publication Number Publication Date
ZA200108263B true ZA200108263B (en) 2003-02-11

Family

ID=23110719

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108263A ZA200108263B (en) 1999-04-09 2001-10-08 Novel recombinant and mutant herpesviruses.

Country Status (9)

Country Link
US (1) US6299882B1 (xx)
EP (1) EP1171608A2 (xx)
JP (2) JP2002541797A (xx)
AU (1) AU4223900A (xx)
BR (1) BR0009640A (xx)
CA (1) CA2366541C (xx)
MX (1) MXPA01010273A (xx)
WO (1) WO2000061736A2 (xx)
ZA (1) ZA200108263B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
EP1178111A1 (en) 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
AU2003239589A1 (en) 2002-05-24 2003-12-12 Schering-Plough Ltd. Eta-1 gene and methods for use
CN101135762A (zh) * 2006-09-01 2008-03-05 深圳富泰宏精密工业有限公司 镜头组件及其制造方法
CN103370079B (zh) * 2010-10-18 2016-08-10 英特维特国际股份有限公司 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗
BR112014008161A2 (pt) 2011-10-21 2017-04-11 Intervet Int Bv vírus da doença de marek não patogênico recombinante, método para a preparação do mesmo, molécula do ácido nucleico, célula hospedeira, vacina para aves domésticas, método para a preparação de uma vacina, uso de um vírus da doença de marek não patogênico recombinante, e, método de vacinação de aves domésticas
TR201818883T4 (tr) * 2011-10-21 2019-01-21 Intervet Int Bv Enfeksiyöz laringotrakeit virüsü ve Newcastle hastalığı virüsü antijenlerini kodlayan rekombinant patojenik olmayan marek hastalığı virüsü yapıları.
IN2014CN04833A (xx) 2011-11-30 2015-09-18 Merial Ltd
US9114108B2 (en) 2011-11-30 2015-08-25 Merial, Inc. Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
US9950059B2 (en) * 2014-02-25 2018-04-24 The United States Of America, As Represented By The Secretary Of Agriculture. Immunogenic composition
HUE061405T2 (hu) 2016-06-17 2023-06-28 Intervet Int Bv Nem patogén Marek-betegség vírus konstruktok, amelyek fertõzõ laryngotracheitis vírus és fertõzõ bursitis vírus antigéneket kódolnak
EP3554536B1 (en) 2016-12-14 2022-10-26 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
WO2019072964A1 (en) 2017-10-12 2019-04-18 Intervet International B.V. RECOMBINANT NON-PATHOGENIC MAREK DISEASE VIRUS CONSTRUCTS ENCODING MULTIPLE HETEROLOGOUS ANTIGENS
EP3768326A1 (en) * 2018-03-19 2021-01-27 Boehringer Ingelheim Vetmedica GmbH Ehv insertion site ul43
KR20210088655A (ko) * 2018-11-06 2021-07-14 베링거잉겔하임베트메디카게엠베하 조류 인플루엔자 바이러스 h5 서브타입에 대한 면역원성 조성물
EP4028510A1 (en) 2019-09-11 2022-07-20 Zoetis Services LLC Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
BR112022025733A2 (pt) 2020-06-17 2023-03-07 Boehringer Ingelheim Vetmedica Gmbh Vetores hvt recombinantes expressando hemaglutinina de influenza e composições imunogênicas, e produção e usos dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
CA1319101C (en) 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US5151267A (en) 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof

Also Published As

Publication number Publication date
CA2366541A1 (en) 2000-10-19
JP2010187679A (ja) 2010-09-02
BR0009640A (pt) 2002-03-05
CA2366541C (en) 2011-11-29
AU4223900A (en) 2000-11-14
EP1171608A2 (en) 2002-01-16
WO2000061736A9 (en) 2002-06-13
JP2002541797A (ja) 2002-12-10
WO2000061736A2 (en) 2000-10-19
MXPA01010273A (es) 2002-09-18
US6299882B1 (en) 2001-10-09
WO2000061736A3 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
HUP0101464A3 (en) Mutant recombinant allergens
GB9912350D0 (en) Modified cytokine
ZA200108263B (en) Novel recombinant and mutant herpesviruses.
AU1540001A (en) Fluorene-perylene copolymers and uses thereof
AU141983S (en) Chair
EP1180338A4 (en) CHAIR
AU141984S (en) Chair
AU2841801A (en) Triazolotriazinones and the use thereof
AU4675300A (en) Recombinant laminin 5
AU2232399A (en) Recombinant ctb-based vaccines
PL354184A1 (en) The prv-1 gene and use thereof
GB0017000D0 (en) Recombinant microorganisms
GB9929832D0 (en) Mutant CED-6 proteins
TW328697U (en) Improved lifting chair
HK1047116A1 (zh) 來自mage的免疫原性肽及其應用
CA87004S (en) Chair
CA87400S (en) Chair
CA86690S (en) Chair
CA86691S (en) Chair
CA86702S (en) Chair
CA87729S (en) Chair
CA86703S (en) Chair
CA86704S (en) Chair
CA88177S (en) Chair
CA86999S (en) Chair